Weekly Recap | Picard Medical -48.18%, violent swings after reverse split
Weekly Review·
- Picard Medical closed at 4.56 USD this week, marking a cumulative decline of 48.18 % amid severe volatility following a reverse stock split.
- The company faces weak valuation and earnings support, with only 1 institutional coverage holding a neutral rating and a target price of 0 USD.
- Market focus shifts to macroeconomic data releases and potential operational updates, as the stock lacks fundamental catalysts.
